Clinical Trial Update: Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial NCT04273555 evaluating early response to a targeted therapy in stage IV HER2-positive breast cancer using advanced PET/MR imaging has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: HER2-positive Breast Cancer | Phase 1, Phase 2 | Status: WITHDRAWN